Hepatitis B virus infection in South Korea: three decades after universal vaccination

Kim, Jin‐Wook

doi:10.3904/kjim.2013.28.4.408

Cited by 5 publications

(4 citation statements)

References 8 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With implementation of HBV in perinatal vaccination and advance in therapeutic modalities, the prevalence of HBV seroposi-tivity dropped from 8 to 10% in the 1980s and 1990s to 2 to 7% in 2017. 7 9 …”

Section: Introductionmentioning

confidence: 99%

Viral Hepatitis in South Korea

Pak

Alastal

Khan

et al. 2016

Euroasian Journal of Hepato-Gastroenterology

View full text Add to dashboard Cite

In South Korea (S. Korea), viral hepatitis is a major public health burden. Advances in healthcare policy, evidence-based medicine, and therapeutic strategies in S. Korea have brought a rapid change in the sociodemographic and clinical characteristics of viral hepatitis. This review discusses the innovative approaches that S. Korea has taken to curb the epidemic of viral hepatitis. In addition, the efficacy of various preventive and therapeutic modalities is discussed. This review aims to provide a brief overview to guide future research direction and healthcare policy changes.How to cite this article: Pak SC, Alastal Y, Khan Z, Darr U. Viral Hepatitis in South Korea. Euroasian J Hepato-Gastroenterol 2017;7(2):163-165.

show abstract

Section: Introductionmentioning

confidence: 99%

Viral Hepatitis in South Korea

Pak

Alastal

Khan

et al. 2016

Euroasian Journal of Hepato-Gastroenterology

View full text Add to dashboard Cite

show abstract

“…In a large study including 370,285 adult Korean men, vaccinated people (vaccinated with HBsAg and anti-HBs) had a 42% reduced risk of HCC compared to that of non-vaccinated controls (unvaccinated and HBs-Ag and anti-HBs) [ 45 ]. The number of HBV carriers has also continuously decreased in recent decades [ 46 ]. In a nationwide Taiwanese study, where universal vaccine coverage started in 1986, the vaccinated cohort had a 70% reduced risk of HCC after a 20-year follow-up period [ 47 ].…”

Section: Liver Cancermentioning

confidence: 99%

Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan–Korea Oncology Consortium

Rim

Lee

Musaev

et al. 2022

IJERPH

View full text Add to dashboard Cite

The health burden of cancer increases in Uzbekistan as the country develops and the life expectancy increases. Management of such a burden requires efficient screening, treatment optimization, and investigation of the causes of cancer. The Ministry of Health of Uzbekistan formed an advisory consortium, including clinical oncology and healthcare management experts from Uzbekistan and South Korea, to design a strategy for cancer management. Our consortium has analyzed six cancer types with high morbidity and mortality in Uzbekistan by classifying them into three categories (breast, cervical (gynecologic cancers), lung, liver (cancer common in men), stomach, and colorectal cancers (gastrointestinal cancers)). Lung and liver cancers are common causes of death in men after middle age—they can yield a serious health burden on the country and ruin the livelihood of families. In this review, we will analyze the oncologic literature and suggest practical recommendations for the treatment and prevention of lung and liver cancer in Uzbekistan. Data from South Korea, which has conducted nationwide screening for two decades and made progress in improving prognosis, will be discussed as a comparative control.

show abstract

“…Moreover, since use of therapeutic drugs, such as T-cell-related immunosuppressants and biologics, interest in the link between psoriasis and infectious diseases has increased. Among infectious diseases, hepatitis B virus (HBV) is the cause of chronic liver disease in 60% to 70% of cases in Korea 3 . HBV is an important cause of hepatic cancer.…”

mentioning

confidence: 99%

“…The prevalence of HBV infection was relatively low in both groups. This result was likely influenced by the National Immunization Program initiated in 1995 and the Hepatitis B Perinatal Transmission Prevention Program initiated in 2002 in Korea 3 . Although the rate of HBV infection in Korea was 6.6% to 8.6% in the 1980s 10 , the rate decreased to 2.98% in 2010 after implementation of these programs 3 10 .…”

mentioning

confidence: 99%